The overall aim of the project is to validate, explore the basis of, update, and disseminate the approach developed under CA46732 for assessing the nature and intensity of empirical drug interactions (Loewe synergism, Loewe antagonism, Loewe additivity, synergism, antagonism and coalism), called the universal response surface approach (URSA). This proposal for the continuation of CA46732 emphasizes the critical need for laboratory experiments to explore a set of questions which came about as a result of the mathematical/statistical modeling work on drug interactions completed during the last three years. To accomplish the singular, focused aim of facilitating URSA to make a large positive impact on the conduct of research worldwide into the efficacy of anticancer drug combinations, several subprojects will be completed: l. The validity and utility of a set of theoretical/empirical mathematical/statistical models, which were derived to describe concentration-effect (dose-response) phenomena and agent interaction, will be investigated in laboratory studies, specifically designed for this goal, of anticancer agents and combinations of agents with three assays, a total growth assay (TGA), a colony count assay (CCA), and an individual colony formation assay (iCFA). 2. Based upon the results of subproject #1, older models will be modified when appropriate, and newer models will be created and tested when needed. Improvements will also be made to design and model-fitting techniques. 3. In order to investigate the mechanistic basis of anticancer drug interactions, the relationship between the empirical models developed under CA46732, with a set of theoretical models of intracellular metabolism will be explored. 4. The first version of the software package, SYNFIT, developed under CA46732, will be distributed, comments solicited from users, and appropriate improvements and enhancements made. Specific enhancements already planned include: a) the incorporation of generalized nonlinear modeling procedures, after rival numerical algorithms for generalized nonlinear modeling have been compared; b) the incorporation of D-optimal and other statistical experimental design procedures, after rival numerical algorithms for these procedures have been compared; c) the incorporation of 3-D graphical procedures.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Project (R01)
Project #
3R01RR010742-05S1
Application #
2040191
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1989-04-01
Project End
1997-03-31
Budget Start
1995-09-01
Budget End
1997-03-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Brun, Yseult Francoise; Greco, William R (2010) Characterization of a three-drug nonlinear mixture response model. Front Biosci (Schol Ed) 2:454-67
Khinkis, Leonid A; Krzyzanski, Wojciech; Jusko, William J et al. (2009) D-optimal designs for parameter estimation for indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn 36:523-39
Brun, Yseult F; Varma, Ram; Hector, Suzanne M et al. (2008) Simultaneous modeling of concentration-effect and time-course patterns in gene expression data from microarrays. Cancer Genomics Proteomics 5:43-53
Brun, Yseult F; Dennis, Carly G; Greco, William R et al. (2007) Modeling the combination of amphotericin B, micafungin, and nikkomycin Z against Aspergillus fumigatus in vitro using a novel response surface paradigm. Antimicrob Agents Chemother 51:1804-12
Varma, Ram; Hector, Suzanne; Greco, William R et al. (2007) Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells. Cancer Chemother Pharmacol 59:711-23
Kau, Yi-Chuan; Hung, Yu-Chun; Zizza, Anthony M et al. (2006) Efficacy of lidocaine or bupivacaine combined with ephedrine in rat sciatic nerve block. Reg Anesth Pain Med 31:14-8
Varma, Rama R; Hector, Suzanne M; Clark, Kimberly et al. (2005) Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. Oncol Rep 14:925-32
Faessel, Helene M; Slocum, Harry K; Rustum, Youcef M et al. (2003) Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells. Int J Oncol 23:401-9
White, Donald B; Slocum, Harry K; Brun, Yseult et al. (2003) A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example. Curr Drug Metab 4:399-409
Slocum, H K; Parsons, J C; Winslow, E O et al. (2000) Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694). Cytometry 41:252-60

Showing the most recent 10 out of 18 publications